Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Clinical Nephrology
|
July 31, 2009
Revisiting essential hypertension--a "mechanism-based" approach may argue for a better definition of hypertension
L A Calò
Kidney International
|
March 11, 2006
Vascular tone control in humans: insights from studies in Bartter's/Gitelman's syndromes
L A Calò
Minerva Medica
|
January 11, 2007
[Impact of metabolic syndrome on chronic kidney disease]
L A Calò
Journal of Endocrinological Investigation
|
September 8, 2006
Aldosterone and thrombosis formation: implications for ischemic and atherosclerotic heart disease
L A Calò, D Armanini
Journal of Endocrinological Investigation
|
March 6, 2015
Mechanistic approach to the pathophysiology of target organ damage in hypertension from studies in a human model with characteristics opposite to hypertension: Bartter's and Gitelman's syndromes
L A Calò, G Maiolino
Clinical Nephrology
|
March 30, 2007
Aborted sudden cardiac death in two patients with Bartter's/Gitelman's syndromes
R Scognamiglio, C Negut, L A Calò
QJM : Monthly Journal of the Association of Physicians
|
December 19, 2019
ACE2/Angiotensin 1-7 protective anti-inflammatory and antioxidant role in hyperoxic lung injury: support from studies in Bartter's and Gitelman's syndromes
L A Calò, M Rigato, G Bertoldi
QJM : Monthly Journal of the Association of Physicians
|
December 12, 2018
The importance of chronic magnesium deficiency in human disease and the Gitelman's syndrome paradox
L A Calò, V Ravarotto, F Simioni
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
April 25, 2006
[Antioxidants, carnitine and erythropoietin]
L A Calò, L Bertipaglia, E Pagnin
Clinical Nephrology
|
March 14, 2009
Erythropoietin, heme oxygenase-1 and vascular tissue protective effects
P A Davis, P Mormino, L A Calò
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Clinical Nephrology
|
July 31, 2009
Revisiting essential hypertension--a "mechanism-based" approach may argue for a better definition of hypertension
L A Calò
Kidney International
|
March 11, 2006
Vascular tone control in humans: insights from studies in Bartter's/Gitelman's syndromes
L A Calò
Minerva Medica
|
January 11, 2007
[Impact of metabolic syndrome on chronic kidney disease]
L A Calò
Journal of Endocrinological Investigation
|
September 8, 2006
Aldosterone and thrombosis formation: implications for ischemic and atherosclerotic heart disease
L A Calò, D Armanini
Journal of Endocrinological Investigation
|
March 6, 2015
Mechanistic approach to the pathophysiology of target organ damage in hypertension from studies in a human model with characteristics opposite to hypertension: Bartter's and Gitelman's syndromes
L A Calò, G Maiolino
Clinical Nephrology
|
March 30, 2007
Aborted sudden cardiac death in two patients with Bartter's/Gitelman's syndromes
R Scognamiglio, C Negut, L A Calò
QJM : Monthly Journal of the Association of Physicians
|
December 19, 2019
ACE2/Angiotensin 1-7 protective anti-inflammatory and antioxidant role in hyperoxic lung injury: support from studies in Bartter's and Gitelman's syndromes
L A Calò, M Rigato, G Bertoldi
QJM : Monthly Journal of the Association of Physicians
|
December 12, 2018
The importance of chronic magnesium deficiency in human disease and the Gitelman's syndrome paradox
L A Calò, V Ravarotto, F Simioni
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
April 25, 2006
[Antioxidants, carnitine and erythropoietin]
L A Calò, L Bertipaglia, E Pagnin
Clinical Nephrology
|
March 14, 2009
Erythropoietin, heme oxygenase-1 and vascular tissue protective effects
P A Davis, P Mormino, L A Calò
Page
of 4